相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of Protective Potential of Yersinia pestis Outer Membrane Protein Antigens as Possible Candidates for a New-Generation Recombinant Plague Vaccine
Tatiana E. Erova et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Deletion of the Braun Lipoprotein-Encoding Gene and Altering the Function of Lipopolysaccharide Attenuate the Plague Bacterium
Jian Sha et al.
INFECTION AND IMMUNITY (2013)
Intranasal Prophylaxis with CpG Oligodeoxynucleotide Can Protect against Yersinia pestis Infection
Anthony J. Hickey et al.
INFECTION AND IMMUNITY (2013)
In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine
Pan Tao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Anthrax Vaccine Antigen-Adjuvant Formulations Completely Protect New Zealand White Rabbits against Challenge with Bacillus anthracis Ames Strain Spores
Kristina K. Peachman et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
The natural history and incidence of Yersinia pestis and prospects for vaccination
E. D. Williamson et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Progress on plague vaccine development
Jason A. Rosenzweig et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2011)
Acceptable Levels of Endotoxin in Vaccine Formulations During Preclinical Research
Luis A. Brito et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Structure of the Three N-Terminal Immunoglobulin Domains of the Highly Immunogenic Outer Capsid Protein from a T4-Like Bacteriophage
Andrei Fokine et al.
JOURNAL OF VIROLOGY (2011)
Purification and characterization of a recombinant Yersinia pestis V-F1 Reversed fusion protein for use as a new subunit vaccine against plague
Jeremy L. Goodin et al.
PROTEIN EXPRESSION AND PURIFICATION (2011)
Involvement of CD8+T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge
Shixia Wang et al.
VACCINE (2011)
Highly effective generic adjuvant systems for orphan or poverty-related vaccines
Mangala Rao et al.
VACCINE (2011)
Structure of the Small Outer Capsid Protein, Soc: A Clamp for Stabilizing Capsids of T4-like Phages
Li Qin et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Functional analysis of the highly antigenic outer capsid protein, Hoc, a virus decoration protein from T4-like bacteriophages
Taheri Sathaliyawala et al.
MOLECULAR MICROBIOLOGY (2010)
MetaMHC: a meta approach to predict peptides binding to MHC molecules
Xihao Hu et al.
NUCLEIC ACIDS RESEARCH (2010)
TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague
Jr-Shivan Lin et al.
VACCINE (2010)
Flagellin-F1-V Fusion Protein Is an Effective Plague Vaccine in Mice and Two Species of Nonhuman Primates
Steven B. Mizel et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Prospects for new plague vaccines
Valentina A. Feodorova et al.
EXPERT REVIEW OF VACCINES (2009)
Plague vaccines and the molecular basis of immunity against Yersinia pestis
Lauriane E. Quenee et al.
HUMAN VACCINES (2009)
Characterization of the rat pneumonic plague model: infection kinetics following aerosolization of Yersinia pestis CO92
Stacy L. Agar et al.
MICROBES AND INFECTION (2009)
CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague
Kei Amemiya et al.
VACCINE (2009)
Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells
Yoonkyung Do et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Current challenges in the development of vaccines for pneumonic plague
Stephen T. Smiley
EXPERT REVIEW OF VACCINES (2008)
Immune defense against pneumonic plague
Stephen T. Smiley
IMMUNOLOGICAL REVIEWS (2008)
Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92
Stacy L. Agar et al.
MICROBIOLOGY-SGM (2008)
Plague: Past, present, and future
Nils Chr. Stenseth et al.
PLOS MEDICINE (2008)
Assembly of the small outer capsid protein, Soc, on bacteriophage T4: A novel system for high density display of multiple large anthrax toxins and foreign proteins on phage capsid
Qin Li et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague
Jeremy L. Goodin et al.
PROTEIN EXPRESSION AND PURIFICATION (2007)
Vaccination with live Yersinia pestis primes CD4 an CD8 T cells that synergistically protect against lethal pulmonary Y pestis infection
Alexander V. Philipovskiy et al.
INFECTION AND IMMUNITY (2007)
Multicomponent anthrax toxin display and delivery using bacteriophage T4
Sathish B. Shivachandra et al.
VACCINE (2007)
Mutations in the Yersinia pseudotuberculosis type III secretion system needle protein, YscF, that specifically abrogate effector translocation into host cells
Alison J. Davis et al.
JOURNAL OF BACTERIOLOGY (2007)
Immunogenicity of a Yersinia pestis vaccine antigen monomerized by circular permutation
David A. Chalton et al.
INFECTION AND IMMUNITY (2006)
Bacteriophage T4 capsid: A unique platform for efficient surface assembly of macromolecular complexes
Qin Li et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Sequential proteolytic processing of the capsular Caf1 antigen of Yersinia pestis for major histocompatibility complex class II-restricted presentation to T lymphocytes
Julie A. Musson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines
Taheri Sathaliyawala et al.
JOURNAL OF VIROLOGY (2006)
Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV
Kristin L. DeBord et al.
INFECTION AND IMMUNITY (2006)
Cell-mediated protection against pulmonary Yersinia pestis infection
MA Parent et al.
INFECTION AND IMMUNITY (2005)
Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague
BS Powell et al.
BIOTECHNOLOGY PROGRESS (2005)
LcrV plague vaccine with altered immunomodulatory properties
KA Overheim et al.
INFECTION AND IMMUNITY (2005)
Yersinia rLcrV and rYopB inhibits the activation of murine peritoneal macrophages in vitro
A Sodhi et al.
IMMUNOLOGY LETTERS (2005)
Human volunteers receiving Escherichia coli phage T4 orally:: a safety test of phage therapy
A Bruttin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Immunization of mice with YscF provides protection from Yersinia pestis infections -: art. no. 38
JS Matson et al.
BMC MICROBIOLOGY (2005)
Human immune response to a plague vaccine comprising recombinant F1 and V antigens
ED Williamson et al.
INFECTION AND IMMUNITY (2005)
Risk of person-to-person transmission of pneumonic plague
JL Kool
CLINICAL INFECTIOUS DISEASES (2005)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Interleukin-10 and inhibition of innate immunity to yersiniae: Roles of Yops and LcrV (V antigen)
RR Brubaker
INFECTION AND IMMUNITY (2003)
Structure and biogenesis of the capsular F1 antigen from Yersinia pestis:: Preserved folding energy drives fiber formation
AV Zavialov et al.
CELL (2003)
Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression
A Sing et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Plague as a biological weapon - Medical and public health management
TV Inglesby et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
